Related Experiment Video
Updated: Jun 6, 2025

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
Published on: May 2, 2013
Impaired complement regulation drives chronic lung allograft dysfunction after lung transplantation
Hrishikesh S Kulkarni1,2, Laneshia K Tague1, Daniel R Calabrese3,4
1Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
Genetic predisposition to complement activation is linked to worse outcomes after lung transplantation (LTx). This genetic factor promotes B cell activation, increasing the risk of chronic lung allograft dysfunction (CLAD).
Area of Science:
- Immunology
- Transplantation Science
- Genetics
Background:
- Chronic lung allograft dysfunction (CLAD) is a major cause of mortality following lung transplantation (LTx).
- The complement system plays a crucial role in innate and adaptive immunity, becoming active early after LTx.
- Understanding the genetic factors influencing complement activation is vital for improving LTx outcomes.
Purpose of the Study:
- To investigate the association between a specific genetic polymorphism in complement component 3 (C3R102G) and CLAD-free survival in LTx recipients.
- To explore the role of impaired complement regulation in adaptive alloimmunity and CLAD development.
- To determine the impact of complement activation on B cell populations and donor-specific antibody (DSA) levels.
Main Methods:
- Analysis of a functional C3 polymorphism (C3R102G) in two independent LTx recipient cohorts.
- Assessment of CLAD-free survival in relation to C3R102G status, particularly in DSA-positive recipients.
- Utilizing a mouse orthotopic lung transplantation model to study the effects of impaired complement regulation on graft pathology and immune cell infiltration.
Main Results:
- The C3R102G polymorphism, present in over one-third of LTx recipients, was associated with significantly worse CLAD-free survival.
- This association was more pronounced in recipients who developed donor-specific antibodies (DSA).
- In a mouse model, impaired complement regulation led to more severe airway lesions and increased intragraft accumulation of memory B cells and antibody-secreting cells, correlating with higher DSA levels.
Conclusions:
- A genetic predisposition to enhanced complement activation, via the C3R102G polymorphism, is linked to poorer CLAD-free survival after lung transplantation.
- Impaired complement regulation promotes B cell activation and antibody production, contributing to the development of CLAD.
- Targeting complement pathways may offer a therapeutic strategy to mitigate CLAD and improve long-term lung allograft survival.
More Related Videos
06:15Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
Published on: November 10, 2023
04:42Author Spotlight: Analyzing Fibrosis Development in Chronic Lung Allograft Rejection Using Picrosirius Red Staining in Mouse Models
Published on: March 21, 2025
Related Concept Videos
Cell-mediated Immune Responses
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...